Tolerability of rofecoxib versus naproxen.

Suppr

超能文献

作者信息

Hanauer Lonnie B

出版信息

Ann Intern Med. 2004 Jun 15;140(12):1059; author reply 1060. doi: 10.7326/0003-4819-140-12-200406150-00020.

DOI:10.7326/0003-4819-140-12-200406150-00020

PMID:15197026

Abstract

摘要

相似文献

Tolerability of rofecoxib versus naproxen.

Ann Intern Med. 2004 Jun 15;140(12):1059; author reply 1060. doi: 10.7326/0003-4819-140-12-200406150-00020.

Tolerability of rofecoxib versus naproxen.

Ann Intern Med. 2004 Jun 15;140(12):1059-60; author reply 1060. doi: 10.7326/0003-4819-140-12-200406150-00022.

Tolerability of rofecoxib versus naproxen.

Ann Intern Med. 2004 Jun 15;140(12):1059; author reply 1060. doi: 10.7326/0003-4819-140-12-200406150-00021.

Summaries for patients. Gastrointestinal side effects of rofecoxib and naproxen.

Ann Intern Med. 2003 Oct 7;139(7):I29. doi: 10.7326/0003-4819-139-7-200310070-00001.

Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.

Ann Intern Med. 2003 Oct 7;139(7):539-46. doi: 10.7326/0003-4819-139-7-200310070-00005.

Is rofecoxib safer than naproxen?

J Fam Pract. 2001 Mar;50(3):204.

Report of specific cardiovascular outcomes of the ADVANTAGE trial.

Ann Intern Med. 2005 Jul 19;143(2):158-9. doi: 10.7326/0003-4819-143-2-200507190-00118. Epub 2005 Jun 20.

The lessons of Vioxx.

N Engl J Med. 2005 Sep 29;353(13):1420-1; author reply 1420-1. doi: 10.1056/NEJMc055294.

Lower gastrointestinal complications of nonsteroidal anti-inflammatory drugs.

Curr Gastroenterol Rep. 2003 Oct;5(5):397-8. doi: 10.1007/s11894-003-0052-4.

Upper gastrointestinal toxicity of rofecoxib and naproxen.

N Engl J Med. 2001 May 3;344(18):1398; author reply 1398-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Tolerability of rofecoxib versus naproxen.

Ann Intern Med. 2004 Jun 15;140(12):1059; author reply 1060. doi: 10.7326/0003-4819-140-12-200406150-00020.

Tolerability of rofecoxib versus naproxen.

Ann Intern Med. 2004 Jun 15;140(12):1059-60; author reply 1060. doi: 10.7326/0003-4819-140-12-200406150-00022.

Tolerability of rofecoxib versus naproxen.

Ann Intern Med. 2004 Jun 15;140(12):1059; author reply 1060. doi: 10.7326/0003-4819-140-12-200406150-00021.

Summaries for patients. Gastrointestinal side effects of rofecoxib and naproxen.

Ann Intern Med. 2003 Oct 7;139(7):I29. doi: 10.7326/0003-4819-139-7-200310070-00001.

Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.

Ann Intern Med. 2003 Oct 7;139(7):539-46. doi: 10.7326/0003-4819-139-7-200310070-00005.

Is rofecoxib safer than naproxen?

J Fam Pract. 2001 Mar;50(3):204.

Report of specific cardiovascular outcomes of the ADVANTAGE trial.

Ann Intern Med. 2005 Jul 19;143(2):158-9. doi: 10.7326/0003-4819-143-2-200507190-00118. Epub 2005 Jun 20.

The lessons of Vioxx.

N Engl J Med. 2005 Sep 29;353(13):1420-1; author reply 1420-1. doi: 10.1056/NEJMc055294.

Lower gastrointestinal complications of nonsteroidal anti-inflammatory drugs.

Curr Gastroenterol Rep. 2003 Oct;5(5):397-8. doi: 10.1007/s11894-003-0052-4.

Upper gastrointestinal toxicity of rofecoxib and naproxen.

N Engl J Med. 2001 May 3;344(18):1398; author reply 1398-9.